Clinical Trial Search

Primary: Difference in Systolic Blood Pressure (SBP) — 131.8; 132.0; 129.1; 129.1 mmHg

Primary: Composite Adverse Perinatal Outcome — 353; 427; 272; 336 Participants — p=<0.001

Primary: Adherence to the American College of Obstetricians and Gynecologists Guideline of Postpartum Blood Pressure Check Within 10 Days Postpartum — 59; 89 Participants…

Primary: Average Mean Arterial Blood Pressure- Mild Group — 93; 93 mmHg

Primary: Proportion of Participants With Recorded Blood Pressure Values in Office — 43; 44; 49; 56 Participants

Primary: Number of Participants Whose Blood Pressure Was Assessed in the First Ten Days Following Discharge — 45; 95 Participants

Primary: Time to Achieve Non Severe Range Blood Pressure — 10; 20 minutes

Primary: Number of Participants With Stage 2 Hypertension — 8; 12 Participants

Primary: Number of Participants With Persistent Postpartum Hypertension Defined as Systolic Blood Pressure ≥ 150 and/or Diastolic Blood Pressure ≥ 100 mmHg — 26; 34 Participants

Primary: Microvascular Endothelial Function (Cutaneous Conductance, %Maximum) — 95; 77 % of maximal cutaneous conductance

Primary: Length of Stay — 73.5; 72.0 hours

Primary: Mean Systolic Blood Pressure During Hour After Study Drug — 147; 152 mmHg

Primary: Percent of Participants Eligible, Enrolled and Retained (Feasibility) — 61 Participants

Primary: Aim 1: Number of Participants Enrolled — 55 Participants

Primary: Pregnancy Loss or NICU Admission for Greater Than 48 Hours — 155; 150 participants

Primary: Persistently Elevated Blood Pressures 7 Days Postpartum — 10; 23 Participants — p=0.03

Primary: Duration of Severe-range Hypertension After Delivery — 38.0; 35.3 hours — p=0.3

Primary: Number of Participants With the Change in Blood Pressure (Both Systolic and Diastolic) Under the Treatment of NIfedipine 30mg XL Versus Placebo — 18; 27 Participants

Primary: Retention and Adherence — 12; 11 Participants

Primary: Cutaneous Conductance (%Maximum) Response to Acetylcholine — 89.4; 72.5 % of maximal cutaneous conductance

Primary: Change in Pulsatility Index (PI) — -0.56; -0.53; -0.43; -0.88 ratio

Primary: Nocturnal Blood Pressure — 128.2; 124.7; 70.6; 68.8 mmHg — p=0.45

Primary: Blood Pressure (BP) Surveillance Adherence — 0.0; 61.1 percentage of recommended BPs reported

Primary: Mean Arterial Blood Pressure (MAP) — 88.9; 86.8 mmHg

Primary: Eating Habits Confidence Survey — 4.2; 4.5 units on a scale

Primary: Mean Arterial Pressure — 93; 94 mm Hg — p=0.54

Primary: Median Number of Remote Blood Pressure (rBPM) Measurements Obtained Per Participant — 6 Number of rBPM measurements

Primary: Number of Participants With Preeclampsia Diagnosis With Severe Features Based on Clinician Diagnosis — 37; 41 Participants

Primary: Prolonged Hospitalization — 13; 17 Participants

Primary: Mean Change From Baseline in Trough Sitting Systolic Blood Pressure (SiSBP) at Week 8 — -12.1; -6.8 mm Hg